Searchable abstracts of presentations at key conferences in endocrinology

ea0049s14.2 | Searching for the cause and approach in ectopic hormone syndromes | ECE2017

Searching for the cause and approach in ectopic hormone syndromes: rare acromegaly

Borson-Chazot Francoise

Acromegaly secondary to ectopic growth hormone-releasing hormone (GHRH) is rare accounting for less than 1% of cases of acromegaly. Less than 100 cases have been reported in the literature mainly as case reports, except for a nationwide French series of 21 cases. Ectopic acromegaly occurs more frequently in women who represent 2/3 of cases. Median age at diagnosis is 41 years but ranges from adolescence to elderly. GHRH secreting neuroendocrine tumors are usually well differen...

ea0063gp172 | Obesity (1) | ECE2019

Pituitary surgery as first-line therapy for microprolactinomas

Teulade Marie , Lasolle Helene , Vasiljevic Alexandre , Borson-Chazot Francoise , Jouanneau Emmanuel , Raverot Gerald

Introduction: Dopamine agonists (DA), reference treatment for microprolactinomas, rarely allow long term remission. The performance of endoscopic pituitary surgery should be examined as first-line treatment.Objective: To evaluate the remission rate of microprolactinoma operated by endoscopic transphenoidal approachMethods: We retrospectively studied the surgical results of the 35 microprolactinomas operated between 2010 to 2017 in ...

ea0063gp238 | Anterior and Posterior Pituitary | ECE2019

Immune checkpoint inhibitors therapy-induced hypophysitis is frequently associated with previous thyroid disorders: results from ImmuCare study

Levy Manon , Abeillon Juliette , Borson-Chazot Francoise , Dalle Stephane , Raverot Gerald , Cugnet-Anceau Christine

Context: The immune checkpoint inhibitor (ICI) therapy is frequently used to treat advanced cancers. Autoimmune adverse events have been reported, such as endocrine side effects including frequent thyroid disorders and more rarely hypophysitis. The aim of this study was to describe retrospectively the association thyroiditis-hypophysitis.Patients and method: From 99 patients with endocrine side effects of the ImmuCare cohort, 18 patients with hypophysiti...

ea0049ep966 | Pituitary - Clinical | ECE2017

Gender differences in real-life GH dosing patterns in adults with GH deficiency (AGHD): experience from a Registry in France

Borson-Chazot Francoise , Hacques Evguenia , Pascal-Vigneron Veronique , Salenave Sylvie , Villette Beatrice

Introduction: Usually GHD women require higher GH doses than males, especially those with exogenous oestrogens (guidelines). This fact was assessed in real-life practice in France.Methods: Data were from a Registry in 84 sites treating AGHD (Norditropin®) up to 5 years. Naïve patients did not receive GH 6 months before inclusion. Statistics were descriptive.Results: 328 patients (129 naïve) were included; mean age 49...

ea0041oc13.4 | Pituitary Clinical | ECE2016

Diagnosis and management of thyrotropin-secreting pituitary tumors: a single center experience with a long-term follow-up of 30 patients

Capraru Oana-Maria , Gaillard Celine , Vasiljevic Alexandre , Raverot Veronique , Borson-Chazot Francoise , Jouanneau Emmanuel , Raverot Gerald

TSH secreting pituitary adenomas are rare tumours for which the treatment of choice is neurosurgery but in some cases medical treatment with somatostatin analogs (SSA) can lead to a good control of symptoms and shrinkage of the tumour.The objective of this study was to review 30 patients diagnosed with TSH-omas between October 1981–July 2014, followed-up for a median of 43.93 months (1.12–192.11) in our University Hospital from Lyon, France.</p...

ea0070aep674 | Pituitary and Neuroendocrinology | ECE2020

A key role for conservative treatment in the management of pituitary apoplexy

Marx Claire , Rabilloud Muriel , Borson-Chazot Francoise , Tilikete Caroline , Jouanneau Emmanuel , Raverot Gerald

Objective: The management of pituitary apoplexy, a rare emergency neuroendocrine condition, is controversial. The aim of the present study was to compare the outcome of patients with pituitary apoplexy managed either by a conservative or surgical approach.Methods: A retrospective cohort study including patients diagnosed between 2007 and 2018 in a tertiary French university hospital. Pituitary apoplexy score was retrospectively applied in a perspective o...

ea0070aep862 | Thyroid | ECE2020

Influence of care pathway on thyroid nodule surgery relevance

Castellnou Solene , Jean-Christophe Lifante , Polazzi Stephanie , Pascal Lea , Borson-Chazot Francoise , Duclos Antoine

Objective: Guidelines recommend using fine needle aspiration cytology (FNAC) to guide thyroid nodule surgical indication, however to what extent these guidelines are followed remains unclear. This study aimed to analyze the quality of the preoperative care pathway and the influence of the care pathway on surgical indications relevance.Design: Nationwide historical cohort study based on data from a sample (1/97th) of French health insurance beneficiaries....

ea0022p397 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Incidence, clinical presentation and outcome of differentiated thyroid cancer in young patients aged 10--24 years living in the French Rhone-Alpes region

Sassolas Genevieve , Nejjari Zakia , Berger Nicole , Berger Claire , Bournaud Claire , Peix Jean-Louis , Borson-Chazot Francoise

Differentiated thyroid cancer is rare in children and adolescents. An aggressive clinical presentation, together with a high rate of recurrences contrasting with low mortality, has been reported, especially, before the age of 15 years. Data are mainly issued from historical series from hospital databases.The aim of the study was to analyze, from a population-based registry, the clinical presentation and outcome of differentiated thyroid cancer in young s...

ea0022p398 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Clinical, hormonal and molecular differences in pituitary ACTH adenomas without (silent corticotroph adenomas) or with Cushing's disease

Raverot Gerald , Wierinckx Anne , Jouanneau Emmanuel , Borson-Chazot Francoise , Lachuer Joel , Pugeat Michel , Trouillas Jacqueline

Objective: Silent corticotroph adenomas (SCA) are rare pituitary tumours immunoreactive for ACTH but without clinical evidence of Cushing’s disease. They have been compared to non functioning pituitary adenomas or ACTH adenomas with Cushing’s disease, but no distinction has been made between micro and macro ACTH-adenomas. We characterize SCA on clinical, hormonal and molecular data and compared the characteristic of these tumours with those of macro (MCA) and micro A...

ea0056p741 | Growth hormone IGF axis - basic | ECE2018

IGF1 level and GH dose adjustmentin adults with GH deficiency (AGHD): experience from a Registry in France

Borson-Chazot Francoise , Pascal-Vigneron Veronique , Salenave Sylvie , Hacques Evguenia , Villette Beatrice

Objective: IGF1 is the most useful serum marker for GH dose titration in adults. The authors focused on the GH dose adjustment with extreme IGF1 values (<−2S.D.; >+2S.D.).Methods: French observational study of AGHD patients treated with Norditropin®.Prospective follow up until 5 years.Results (median [Q1; Q3]):: 328 AGHD, 39.2±14.3 years old wer...